Compounders Research Compare

Rein Therapeutics Inc.(RNTX)

Biotechnology · Austin, TX

$0.82-0.00 (-0.41%)

Delayed quote: Oct 6, 2026, 1:44 PM EDT

About Rein Therapeutics Inc.

Rein Therapeutics Inc. operates as a clinical-stage biopharmaceutical enterprise focused on discovering and bringing to market novel therapeutic solutions for various conditions, notably cancer. The company's leading drug candidate, ALRN-6924, is a distinctive cell-penetrating peptide. This compound works by disrupting the harmful interaction between the p53 suppressor proteins, MDM2 and MDMX, and the vital p53 tumor suppressor. Its goal is to reactivate the natural tumor-suppressing pathways in cancers where the p53 gene is still functional, or "wild-type." The organization was founded on August 6, 2001, by Gregory L. Verdine, Rosana Kapeller, Huw M. Nash, Joseph A. Yanchik III, and Loren David Walensky, and its main corporate offices are situated in Austin, Texas.

Austin, TX

10 employees

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: James Brian Windsor

View full financials

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T17:48:01.197Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:48:01.197Z.

Quote observation: 2026-10-06T17:44:40.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -1.83
Quote price: 0.8216

FMP input reference: 6f5be79ac0e7715def3f298c248b41853c7a510be646acbaec4ce361b11b20d4

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

RNTX Earnings Yield Metrics

EARNINGS YIELD

N/A

RNTX Competitors' Earnings Yield

Rein Therapeutics Inc.

Current

Market Cap

$22.97M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TherapeuticsMD, Inc.

Market Cap

$23.61M

Earnings Yield

N/A

TTM Avg

1.20%

3Y Avg

1.20%

5Y Avg

1.20%

LeonaBio, Inc.

Market Cap

$22.62M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Aytu BioPharma, Inc.

Market Cap

$22.11M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Kyntra Bio, Inc.

Market Cap

$24.05M

Earnings Yield

N/A

TTM Avg

0.04%

3Y Avg

0.04%

5Y Avg

0.04%

Modular Medical, Inc.

Market Cap

$21.36M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ABVC BioPharma, Inc.

Market Cap

$24.18M

Earnings Yield

N/A

TTM Avg

0.06%

3Y Avg

0.06%

5Y Avg

0.06%

Atossa Therapeutics, Inc.

Market Cap

$24.54M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Quantum BioPharma Ltd.

Market Cap

$21.50M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Actuate Therapeutics Inc

Market Cap

$20.09M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Rein Therapeutics Inc. (RNTX)	$22.97M	N/A	N/A	N/A	N/A
TherapeuticsMD, Inc. (TXMD)vs ›	$23.61M	N/A	1.20%	1.20%	1.20%
LeonaBio, Inc. (LONA)vs ›	$22.62M	N/A	N/A	N/A	N/A
Aytu BioPharma, Inc. (AYTU)vs ›	$22.11M	N/A	N/A	N/A	N/A
Kyntra Bio, Inc. (KYNB)vs ›	$24.05M	N/A	0.04%	0.04%	0.04%
Modular Medical, Inc. (MODD)vs ›	$21.36M	N/A	N/A	N/A	N/A
ABVC BioPharma, Inc. (ABVC)vs ›	$24.18M	N/A	0.06%	0.06%	0.06%
Atossa Therapeutics, Inc. (ATOS)vs ›	$24.54M	N/A	N/A	N/A	N/A
Quantum BioPharma Ltd. (QNTM)vs ›	$21.50M	N/A	N/A	N/A	N/A
Actuate Therapeutics Inc (ACTU)vs ›	$20.09M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics